Welcome : Guest

Delcath Systems, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Delcath Systems, Inc., which is principally a Late-Stage Clinical Development Company. Illustrated with 39 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-33381
Price: $1950
Company Type: Public
Pages: 41
Date: October 2015
Market Data Tables: 39

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
  DELCATH SYSTEMS, INC. (USA) (Complete Report)Pages : 41|$ 1950.00
1. COMPANY SNIPPETS......1
2. MARKET OVERVIEW......2
Pharmaceuticals......2
Table 1: Speciality Pharmaceuticals Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......2
Table 2: Pharmaceuticals Market by Therapeutic Area in China (2014) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti- Infective, and Others......3
Table 3: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular System, Nervous System, Oncology and Immunomodulating Agents, Systemic Anti-infectives, Musculo-Skeletal System and Others......4
Clinical Research Organization (CRO)......5
Table 4: Clinical Research Organization (CRO)'s Revenue by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for US, and Others......5
Clinical Trials......6
Table 5: Clinical Trials by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for Africa, Asia, Australia, Canada, Europe, Mexico, South America, and United States......6
Cancer Drugs......7
Table 6: Anti-Cancer Drugs Market by Product Type in China (2014) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......7
Table 7: Anti-Cancer Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......8
Table 8: Cancer Care Expenditure by Site Worldwide (2014) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......9
Table 9: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......10
Table 10: Cancer Market by Type in China (2015)-Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......11
Table 11: Cancer-Associated Mucositis Market by Activity Worldwide (2015)-Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......12
Table 12: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......13
Table 13: Skin Cancer by Type Worldwide (2014) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......14
Table 14: Hematological Cancer by Category Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......15
Table 15: Hospital Drug Market by Segment in China (2015)-Percentage Share Breakdown by Value for Anti-Infection, Cardio-Cerebral Vascular, Digest, Neurology, Oncology and Others......16
Table 16: Standard Injectibles Market by Product Worldwide (2015)-Percentage Share Breakdown by Value for Anti-Infectives, Blood, Oncology and Others......17
Table 17: Oncology Market by Product Segment Worldwide (2014) - Percentage Breakdown by Value for Dialysis Catheters, Enteral Feeding, Peripherally Inserted Central Catheters, Ports, Ultrasound, and Others......18
Table 18: Oncology Market by Category in China (2015)-Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......19
Table 19: Clinical Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......20
Table 20: Hereditary Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......21
Table 21: Oncology Drug Market by Region Worldwide (2015)-Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......22
Table 22: Oncology/Hematology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......23
Number of Cancer Patients......24
Table 23: No. of Bladder Cancer Patients by Category in the US (2014) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......24
Table 24: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......25
Table 25: No. of Cancer Patients Death by Type in the US (2014) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......26
Table 26: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......27
Table 27: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......28
Table 28: No. of Solid Cancer Tumor Patients by Type Worldwide (2014) – Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......29
Table 29: Number of Cancer Patients by Type in the US (2014) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......30
Table 30: Number of Cancer Patients by Type Worldwide (2014) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......31
3. COMPETITIVE LANDSCAPE......32
Cancer Drugs......32
Table 31: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......32
Table 32: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015)-Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......33
Table 33: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co, Ltd.......34
Table 34: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......35
Table 35: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......36
Table 36: Market Shares of Leading Oncology Drug Manufacturers in China (2015)-Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......37
Table 37: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......38
Radiation Oncology Equipment......39
Table 38: Market Shares of Leading Radiation Oncology Equipment Manufacturers Worldwide (2015)-Percentage Share Breakdown by Value for Elekta, Siemens AG, Varian Medical Systems and Others......39
Clinical Research Organization (CRO)......40
Table 39: Market Shares of Leading Clinical Research Organization (CRO) Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Charles River Laboratories International, Inc., Covance, Inc., ICON Plc, INC Research, Inventiv Health, Inc., Laboratory Corporation of America Holdings, PAREXEL International, Pharmaceutical Product Development LLC, PRA International, Quest Diagnostics, Inc., Quintiles Transnational Holdings, Inc., Wuxi Pharmatech (Cayman) Inc., and Others......40
4. RECENT INDUSTRY DEVELOPMENT......41